Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Due Diligence - How to Investigate a Stock -- Ignore unavailable to you. Want to Upgrade?

To: ubrx who wrote (66)	3/30/1999 7:51:00 AM
From: Don Pueblo	Respond to of 752

Neither. Depends on the suit, and depends on the company. It's almost run of the mill now that if the stock tanks you can expect a class action suit from the people that failed to read the writing on the wall. If it is something serious, I assume would have found out something about it before I bought the stock in most cases. If I didn't, it scares me. I'm really a big chicken when it comes to stuff that looks weird. As a matter of fact, I have a rule now that I don't invest in biotechs or drug companies at all, just because there are too many variables for me. (My personal rule, don't hassle me about it. <ggg>)